Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Safa FerradjLaboratory of Chemical Engineering, Chemical Engineering Department, Saad Dahlab University, Blida 09000, Algeria.
Madiha Melha YahoumLaboratory of Biomaterials and Transport Phenomena (LBMPT), Nouveau Pôle Urbain, Medea University, Medea 26000, Algeria.
Mounia RebihaFunctional Analysis of Chemical Processes Laboratory, Chemical Engineering Department, Saad Dahlab University, Blida 09000, Algeria.
Ikram NabiLaboratory of Chemical Engineering, Chemical Engineering Department, Saad Dahlab University, Blida 09000, Algeria.
Selma ToumiLaboratory of Biomaterials and Transport Phenomena (LBMPT), Nouveau Pôle Urbain, Medea University, Medea 26000, Algeria.
Sonia LefnaouiLaboratory of Biomaterials and Transport Phenomena (LBMPT), Nouveau Pôle Urbain, Medea University, Medea 26000, Algeria.
Amel Hadj-Ziane-ZafourLaboratory of Chemical Engineering, Chemical Engineering Department, Saad Dahlab University, Blida 09000, Algeria.ORCID 0000-0001-7937-8951
Nabil TouzoutDepartment of Nature and Life Sciences, Faculty of Sciences, Pole Urban Ouzera, University of Medea, Medea 26000, Algeria.ORCID 0000-0002-7091-9990
Hichem TahraouiLaboratory of Biomaterials and Transport Phenomena (LBMPT), Nouveau Pôle Urbain, Medea University, Medea 26000, Algeria.ORCID 0000-0003-2209-6405
Adil MihoubBiophysical Environment Station, Center for Scientific and Technical Research on Arid Regions, Touggourt 30000, Algeria.ORCID 0000-0002-7869-700X
Mahmoud F SeleimanDepartment of Plant Production, College of Food and Agriculture Sciences, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-4779-9414
Nawab AliDepartment of Biosystems and Agricultural Engineering (BAE), College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824, USA.
Jie ZhangSchool of Engineering, Merz Court, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.ORCID 0000-0002-9745-664X
Abdeltif AmraneNational High School of Chemistry of Rennes, Scientific Research National Center (CNRS), ISCR-UMR 6226, Rennes University, F-35000 Rennes, France.ORCID 0000-0003-2622-2384
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
The objective of this study is the development of innovative nanocurcumin-based formulations designed for the treatment and prevention of oxidative stress and diabetes. Nanocurcumin was obtained through a micronization process and subsequently encapsulated within biopolymers derived from corn starch and fenugreek mucilage, achieving encapsulation rates of 75% and 85%, respectively. Subsequently, the encapsulated nanocurcumin was utilized in the formulation of sugar-free syrups based on
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Nanocurcumin-Based Sugar-Free Formulation: Development and Impact on Diabetes and Oxidative Stress Reduction. · full record | OpenQuestion